B. Woggon - Concepedia

Author

B. Woggon

University Hospital of Zurich

Also Known As

B WOGGON, B Woggon, B. Woggon

117

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Zurich University of Zurich

About

B. Woggon is an author at University Hospital of Zurich specializing in medicine, psychiatry, and psychopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	215
2	Social Sciences	7	7	124
3	Engineering	1	1	12
4	Health Sciences	1	1	41
5	Behavioral Sciences	1	1	41

B. Woggon

Publications

517

Citations

H-Index

Page 1

	Year	Citations
Light treatment of seasonal affective disorder in Switzerland Anna Wirz‐Justice, Charlotte Bucheli, Peter Graw, Acta Psychiatrica Scandinavica	1986	184
Consensus Conference on the Methodology of Clinical Trials of Antidepressants, Zurich, march 1988: Report of the Consensus Committee Jules Angst, Per Bech, Pascal Boyer, Pharmacopsychiatry Consensus ConferencePsychiatryMedicinePsychotropic MedicationClinical Trials	1989	52
A Case of Serotonin Syndrome Caused by Venlafaxine and Lithium G. Mekler, B. Woggon Pharmacopsychiatry	1997	50
Speaking behavior and voice sound characteristics associated with negative schizophrenia Hans H. Stassen, Matthias Albers, Jörg Püschel, Journal of Psychiatric Research Behavioral SciencesVoicePsychiatryPsychotic DisorderSchizophrenia	1995	41
The AMDP-System in Clinical Psychopharmacology D Bobon, B. Woggon The British Journal of Psychiatry	1986	21
Interrater Reliability of AMDP and AMP Symptoms S. Kuny, N. von Luckner, R. Baenninger, Modern problems of pharmacopsychiatry/Modern trends in pharmacopsychiatry ReliabilityElectrophysiological EvaluationReliability AnalysisPsychiatryDiagnosis	2015	20
Antipsychotic Efficacy of Fluperlapine B. Woggon, Jules Angst, M. Bartels, Neuropsychobiology	1984	19
Importance of Oxidative Polymorphism on Clinical Efficacy and Side-Effects of Imipramine - A Retrospective Study Jörg Meyer, B. Woggon, A Küpfer Pharmacopsychiatry Retrospective StudyPharmacologyHuman PolymorphismPharmacogenomicsOxidative Polymorphism	1988	18
The effect of L-5-hydroxytryptophan alone and in combination with a decarboxylase inhibitor (Ro-4-4602) in depressive patients. N. Matussek, Jules Angst, Otto Benkert, PubMed Depressive PatientsDecarboxylase InhibitorPsychiatryMedicinePsychotropic Medication	1974	16
Effects and side-effects of bromperidol in comparison with other antipsychotic drugs. B. Woggon Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)	1978	15

Page 1